
IVD Trends and Market Update, March 2022
Description
IVD Trends and Market Update, March 2022
What’s Driving Growth in the IVD Market in 2022?
What Major Trends are Affecting the Market in 2022?
How Has COVID-19 Impacted and Continued to Impact the Market in 2022?
What Product Trends and New Developments Will Shape the IVD Market in 2022?
Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information as of Q1 2022.
The demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly evolving market picture. There are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), personalized medicine and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a core part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.
Kalorama Information continues to be diligent in outlining the IVD market and its rapidly changing landscape. Kalorama Information has been and continues to be superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.
What’s Driving Growth in the IVD Market in 2022?
What Major Trends are Affecting the Market in 2022?
How Has COVID-19 Impacted and Continued to Impact the Market in 2022?
What Product Trends and New Developments Will Shape the IVD Market in 2022?
Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information as of Q1 2022.
The demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly evolving market picture. There are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), personalized medicine and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a core part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.
Kalorama Information continues to be diligent in outlining the IVD market and its rapidly changing landscape. Kalorama Information has been and continues to be superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.
Table of Contents
58 Pages
- IVD Market Demand and Growth
- Effect of COVID-19 on Market Segments
- Selected New - Q4 2021 and Q1 2022 - Core IVD Product Launches, Developments and Trends
- COVID-19 Developments – Q1 2021 Through Q4 2021
- Selected Competitive Leader Updates
- 2021 M&A Activity
- Abbott Laboratories
- Becton Dickinson and Co
- bioMérieux SA
- Danaher Corporation
- Hologic, Inc.
- Ortho Clinical Diagnostics
- PerkinElmer, Inc.
- Quidel Corporation
- Roche Diagnostic
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- Artificial Intelligence in the Lab
- Multiplex and Syndromic Testing
- Advancing Lateral Flow Technologies
- Personalized Medicine
- Point-of-Care
- Mass Spectrometry-based COVID-19 Testing
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.